Cargando…
Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
INTRODUCTION: Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM is highly susceptible to metastasis, which eventually occurs in nearly half of all patients; once metastasis occurs, pat...
Autores principales: | Hu, Yuanyuan, Cai, Jiayang, Ye, Meng, Mou, Qianxue, Zhao, Bowen, Sun, Qian, Lou, Xiaotong, Zhang, Hong, Zhao, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709208/ https://www.ncbi.nlm.nih.gov/pubmed/36466923 http://dx.doi.org/10.3389/fimmu.2022.1037128 |
Ejemplares similares
-
Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022) -
Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma
por: Ma, Xiaochen, et al.
Publicado: (2022) -
Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy
por: Li, Xiaoyan, et al.
Publicado: (2023) -
Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data
por: Wang, Wanpeng, et al.
Publicado: (2023) -
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)